Multifaceted Determinants for Achieving Glycemic Control The International Diabetes Management Practice Study (IDMPS)

被引:230
作者
Chan, Juliana C. N. [1 ]
Gagliardino, Juan Jose [2 ]
Baik, Sei Hyun [3 ]
Chantelot, Jean-Marc [4 ]
Ferreira, Sandra R. G. [5 ]
Hancu, Nicolae [6 ]
Ilkova, Hasan [7 ]
Ramachandran, Ambady [8 ]
Aschner, Pablo [9 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[2] Natl Univ La Plata, Sch Med,Ctr Expt & Appl Endocrinol, Collaborating Ctr Diabet,Natl Sci & Tech Res Coun, WHO,Pan Amer Hlth Org, La Plata, Buenos Aires, Argentina
[3] Korea Univ, Guro Hosp, Dept Internal Med, Seoul, South Korea
[4] Dept Intercontinental Med Affairs, Paris, France
[5] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil
[6] Iuliu Hatieganu Univ Med, Diabet Ctr & Clin, Cluj Napoca, Romania
[7] Istanbul Univ, Cerrahpasa Med Fac, Dept Internal Med, Istanbul, Turkey
[8] Dr A Ramachandrans Diabet Hosp, India Diabet Res Fdn, Madras, Tamil Nadu, India
[9] Javeriana Univ, Endocrinol Unit, Bogota, Colombia
关键词
RISK; INTERVENTION;
D O I
10.2337/dc08-0435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The International Diabetes Mellitus Practice Study is a 5-year survey documenting changes in diabetes treatment practice in developing regions. RESEARCH DESIGN AND METHODS - Logistic regression analysis was used to identify factors for achieving A1C <7% in 11,799 patients (1,898 type 1 diabetic and 9,901 type 2 diabetic) recruited by 937 physicians from 1.7 countries in Eastern Europe (n = 3,519), Asia (n = 5,888), Latin America (n = 2,116), and Africa (n = 276). RESULTS - Twenty-two percent of type 1 diabetic and 36% of type 2 diabetic patients never had A1C measurements. in those with values for A1C, blood pressure, and LDL cholesterol, 7.5% of type 1 diabetic (n = 696) and 3.6% of type 2 diabetic (n = 3,896) patients attained all three recommended targets (blood pressure <130/80 mmHg, LDL cholesterol <100 mg/dl, and A1C <7%). Self-monitoring of blood glucose was the only predictor for achieving the A1C goal in type 1 diabetes (odds ratios: Asia 2.24, Latin America 3.55, and Eastern Europe 2.42). In type 2 diabetes, short disease duration (Asia 0.97, Latin America 0.97, and Eastern Europe 0.82) and treatment With few oral glucose-lowering drugs (Asia 0,64, Latin America 0.76, and Eastern Europe 0,62) were predictors, Other region-specific factors included lack of microvascular complications and old age in Latin America and Asia; health insurance coverage and specialist care in Latin America; lack of obesity and self-adjustment of insulin dosages in Asia; and training by a diabetes educator, self-monitoring of blood glucose in Patients who self-adjusted insulin, and lack of macrovascular complications in Eastern Europe. CONCLUSIONS - in developing countries, factors pertinent to Patients, doctors, and health care systems all impact on glycemic control.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 16 条
  • [1] [Anonymous], 2007, Diabetes Care, V30, pS3
  • [2] Visceral adiposity and risk of type 2 diabetes - A prospective study among Japanese Americans
    Boyko, EJ
    Fujimoto, WY
    Leonetti, DL
    Newell-Morris, L
    [J]. DIABETES CARE, 2000, 23 (04) : 465 - 471
  • [3] Glycemic and risk factor control in type 1 diabetes -: Results from 13,612 patients in a national diabetes register
    Eeg-Olofsson, Katarina
    Cederholm, Jan
    Nilsson, Peter M.
    Gudbjornsdottir, Soffia
    Eliasson, Bjorn
    [J]. DIABETES CARE, 2007, 30 (03) : 496 - 502
  • [4] Antihyperglycaemic treatment of type 2 diabetes:: results from a national diabetes register
    Ellasson, B.
    Eeg-Olofsson, K.
    Cederholm, J.
    Nilsson, P. M.
    Gudbjoernsdottir, S.
    [J]. DIABETES & METABOLISM, 2007, 33 (04) : 269 - 276
  • [5] FARRELL D, 2007, MCKINSEY Q, P87
  • [6] Effect of a multifactorial intervention on mortality in type 2 diabetes
    Gaede, Peter
    Lund-Andersen, Henrik
    Parving, Hans-Henrik
    Pedersen, Oluf
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) : 580 - 591
  • [7] Methodological development:: Structured outcome assessment and community risk monitoring (SORM)
    Grann, M
    Sturidsson, K
    Haggård-Grann, U
    Hiscoke, UL
    Alm, PO
    Dernevik, M
    Gumpert, C
    Hallqvist, J
    Hallquist, T
    Kullgren, G
    Långström, N
    Lotterberg, M
    Nordström, K
    Ståhle, L
    Woodhouse, A
    [J]. INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2005, 28 (04) : 442 - 456
  • [8] From best evidence to best practice: effective implementation of change in patients' care
    Grol, R
    Grimshaw, J
    [J]. LANCET, 2003, 362 (9391) : 1225 - 1230
  • [9] *INT DIAB FED, 2006, DIAB ATL
  • [10] Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512